While all treatment regimens for Hodgkin lymphoma can cause neutropenia, the degree and the chance of neutropenic fever varies, explained Alison J. Moskowitz, MD, medical oncologist, clinical director, lymphoma inpatient unit, Memorial Sloan Kettering Cancer Center.
While all treatment regimens for Hodgkin lymphoma can cause neutropenia, the degree and the chance of neutropenic fever varies, explained Alison J. Moskowitz, MD, medical oncologist, clinical director, lymphoma inpatient unit, Memorial Sloan Kettering Cancer Center.
Transcript
What treatments are more likely to cause patients with Hodgkin lymphoma to become neutropenic?
Standard ABVD [doxorubicin, bleomycin, vinblastine and darcarbacine] chemotherapy certainly causes neutropenia. The interesting thing about it, though, is that the rate of neutropenic fever with ABVD chemotherapy is very low. In fact, for young patients, who are the majority of patients with Hodgkin lymphoma, who are receiving ABVD chemotherapy, I typically do not give growth factor, unless they’ve had a history of having some trouble with getting admitted for neutropenic fever or trouble with infections.
In fact, it’s been shown that we can even treat these patients on time, despite the fact that they’re neutropenic when they come in to see us. I really advocate to try and keep their treatment on time, even if they’re neutropenic, because I think that has an important impact on making sure that we’re optimizing their chance of being cured.
When we bring in brentuximab to that regimen, so brentuximab plus ABVD regimen, it was a little bit of a surprise at first, but the rate of neutropenic fever was much higher than what is expected with ABVD. So, we learned that we have to give growth factor with that regimen, and so that is what I consider to be the standard of care.
The more intense regimen that we sometimes use for Hodgkin lymphoma, which is escalated BEACOPP, certainly has an even higher chance of causing neutropenic fever. We always use growth factor with that regimen. Despite that, some patients will get admitted for neutropenic fever. So, certainly all these regimens cause neutropenia. But, the degree and the chance of neutropenic fever, which is really what we’re trying to prevent when we’re giving growth factor, can vary a little bit.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More